Elaine D. Sun

Chief Financial Officer, Halozyme Therapeutics.

Companies

Recursion PharmaceuticalsBoard member Mar 19, 2025 to now¹
DYNAVAX TECHNOLOGIES CORPBoard member Dec 14, 2021 to now²
Halozyme TherapeuticsChief financial officer Mar 4, 2020 to Apr 1, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Recursion Pharmaceuticals RXRX135,981 shares⁴$494.3K at $3.63Jun 17, 2026
DYNAVAX TECHNOLOGIES CORP0 shares⁵Feb 10, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 17, 2026Granted 88,424 shares of Recursion Pharmaceuticals⁴
Feb 10, 2026Returned to company 29,865 shares of DYNAVAX TECHNOLOGIES CORP⁵
Jun 18, 2025Granted 11,008 shares of Recursion Pharmaceuticals⁶
Jun 11, 2025Granted 5,758 shares of DYNAVAX TECHNOLOGIES CORP⁷
Mar 17, 2025Granted 36,549 shares of Recursion Pharmaceuticals⁸
May 23, 2024Granted 5,357 shares of DYNAVAX TECHNOLOGIES CORP⁹
May 26, 2023Granted 5,357 shares of DYNAVAX TECHNOLOGIES CORP¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARRecursion Pharmaceuticals, Board member
2
SEC EDGARDYNAVAX TECHNOLOGIES CORP, Board member
3
SEC EDGARHalozyme Therapeutics, Chief financial officer
4
SEC EDGARRecursion Pharmaceuticals shares after the filing of Jun 17, 2026
5
SEC EDGARDYNAVAX TECHNOLOGIES CORP shares after the filing of Feb 10, 2026
6
SEC EDGARForm 4 filed Jun 23, 2025
7
SEC EDGARForm 4 filed Jun 13, 2025
8
SEC EDGARForm 4 filed Mar 19, 2025
9
SEC EDGARForm 4 filed May 28, 2024
10
SEC EDGARForm 4 filed May 31, 2023